John Nicholls
Overview
Explore the profile of John Nicholls including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
12.
Smith C, Lee V, Schuessler A, Beagley L, Rehan S, Tsang J, et al.
Oncoimmunology
. 2017 Mar;
6(2):e1273311.
PMID: 28344888
Adoptive T cell therapy has emerged as a powerful strategy to treat human cancers especially haematological malignancies. Extension of these therapies to solid cancers remains a significant challenge especially in...
13.
Pellino G, Kontovounisios C, Tait D, Nicholls J, Tekkis P
Case Rep Oncol
. 2017 Feb;
10(1):112-122.
PMID: 28203173
Background: Few cases of pouch-related cancers have been reported in ulcerative colitis (UC), and squamous cell carcinoma (SCC) is very rare. Method: A systematic review of the literature was performed...
14.
Iqbal F, Thomas G, Tan E, Askari A, Dastur J, Nicholls J, et al.
Dis Colon Rectum
. 2016 Jan;
59(2):132-9.
PMID: 26734972
Background: Transcutaneous sacral nerve stimulation is reported to improve symptoms of fecal incontinence. Chronic constipation may also respond to stimulation, but this is poorly reported in the literature. Objective: The...
15.
Liu W, Wong J, He Q, Wong E, Tang C, Zhang R, et al.
BMC Med Genet
. 2015 Jul;
16:49.
PMID: 26179878
Background: Diffuse oesophageal leiomyomatosis (DOL) is a rare disorder characterized by tumorous overgrowth of the muscular wall of the oesophagus. DOL is present in 5 % of Alport syndrome (AS)...
16.
17.
18.
19.
20.
Chow J, Man W, Mao M, Chen H, Cheung F, Nicholls J, et al.
Mol Cancer Ther
. 2013 Aug;
12(11):2517-28.
PMID: 23979918
Nasopharyngeal carcinoma is a rare but highly invasive cancer. As options of agents for effective combination chemoradiotherapy for advanced nasopharyngeal carcinoma are limited, novel therapeutic approaches are desperately needed. The...